Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Impact of DTG Use During Pregnancy on Birth Outcomes of HIV-Infected Women in the Western Cape, South Africa

Background: The global shift to tenofovir+lamivudine+dolutegravir (TLD) has improved viral suppression in pregnant women living with HIV (WLH) but there are limited data on the combined impact of HIV and maternal body composition on birth outcomes. Methods: We enrolled WLH on TLD and a comparison gr...

Full description

Saved in:
Bibliographic Details
Main Author: Meyer, Jamie
Other Authors: Myer, London
Format: Thesis
Language:English
English
Published: Department of Public Health and Family Medicine 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: The global shift to tenofovir+lamivudine+dolutegravir (TLD) has improved viral suppression in pregnant women living with HIV (WLH) but there are limited data on the combined impact of HIV and maternal body composition on birth outcomes. Methods: We enrolled WLH on TLD and a comparison group of women not living with HIV (WNLH) seeking antenatal care at primary health facilities in Cape Town. Gestational age (GA) was determined via ultrasound by research sonographer; behavioural and demographic data were collected through questionnaires; anthropometry was through clinical examination. Birth outcome data were abstracted from medical records, including pregnancy loss (miscarriage and stillbirth), prematurity (<37weeks GA), low birthweight (LBW) (<2500g), high birthweight (>400g) and size for GA [including small-(SGA) and large-for-GA (LGA) from Intergrowth estimates. Logistic regression models assessed the association between HIV/TLD and birth outcomes adjusting for maternal age, BMI, alcohol use and education; results are reported as adjusted odds ratios (AOR). Results: We followed 1908 women (804 WLH, 1104 HIV-; mean age 28y, median GA at enrolment, 14w; median BMI at enrolment, 31kg/m2 [IQR, 25-35]. Birth outcomes were known for 1869 women (98%) including 65 miscarriages (3.4%), 35 stillbirths (1.9%) and 1769 live births (1735 singletons). Overall rates of prematurity, LBW, HBW, SGA, HBW and LGA were 9.4%, 12%, 13%, 4% and 12%, respectively, and did not differ between WLH and HIV- women. BMI did not affect the association between HIV/TLD and any birth outcome. Independent of HIV/TLD, higher BMI was associated with reductions in prematurity, LBW and SGA. Conclusion: These results suggest few meaningful differences in birth outcomes between WLH on TLD in this setting, where both HIV and obesity are prevalent. Maternal BMI appears to be a more significant driver of birth outcomes than HIV in this cohort.